Title: Research Communications of the 24th ECVIM-CA Congress Document date: 2015_1_10
ID: r59usk02_405
Snippet: The author works at Texas A&M University, whose GI Lab currently offer a commercial assay for faecal Alpha1-Proteinase Inhibitor. Canine chronic enteropathy (CE) is a common, but poorly understood syndrome, with variable response to therapy and prognosis. There is a need for novel biomarkers that are specific for intestinal disease and that provide objective measures of disease severity, progression, and prognosis. Serum citrulline is a useful bi.....
Document: The author works at Texas A&M University, whose GI Lab currently offer a commercial assay for faecal Alpha1-Proteinase Inhibitor. Canine chronic enteropathy (CE) is a common, but poorly understood syndrome, with variable response to therapy and prognosis. There is a need for novel biomarkers that are specific for intestinal disease and that provide objective measures of disease severity, progression, and prognosis. Serum citrulline is a useful biomarker in human intestinal disease as it is specific to the small intestine and indicates globally reduced enterocyte mass and absorptive function in various disease states. It is used to determine, quantitatively, intestinal integrity at the enterocyte level and is not influenced by nutritional or inflammatory status. The aim of this study was to determine whether serum citrulline can be used as a biomarker for CE in dogs.
Search related documents:
Co phrase search for related documents- novel biomarker and objective measure: 1
- novel biomarker and study aim: 1, 2, 3, 4, 5
- novel biomarker and syndrome understand: 1
- novel biomarker and useful biomarker: 1, 2, 3, 4, 5, 6
- objective measure and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
- objective measure and variable response: 1
- prognosis progression and study aim: 1, 2, 3, 4, 5, 6, 7, 8
- prognosis progression and useful biomarker: 1
- prognosis progression disease severity and study aim: 1
- prognosis therapy and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- prognosis therapy and useful biomarker: 1
- serum citrulline and small intestine: 1
- serum citrulline and study aim: 1
- small intestine and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- small intestine and variable response: 1
- study aim and syndrome understand: 1
- study aim and useful biomarker: 1, 2, 3, 4, 5, 6, 7, 8
- study aim and variable response: 1, 2, 3, 4, 5, 6
- useful biomarker and variable response: 1
Co phrase search for related documents, hyperlinks ordered by date